On the contrary, decreased expression of ASRGL1 was significantly associated with poor prognosis and reduced disease-specific survival in endometrioid endometrial adenocarcinoma (Edqvist et al., 2015). The gene discussed is ASRGL1; the disease is endometrial endometrioid adenocarcinoma.